Details for Patent: 9,268,909

Which drugs does patent 9,268,909 protect, and when does it expire?

Patent 9,268,909 protects ABILIFY MYCITE KIT and is included in one NDA.

This patent has twenty-one patent family members in seventeen countries.

Summary for Patent: 9,268,909

Title:	Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device
Abstract:	Provided is an apparatus, system, and method for stabilizing battery voltage of a battery device while optimizing power delivered to a receiver during communication of a broadcast packet. A logic circuit is configured to receive a broadcast packet having a predetermined number of bits for communication by a controller to a receiver located remotely from the controller, determine a number of cycles in which a sampled battery voltage is either greater than or less than or equal to a nominal battery voltage over a first subset of the predetermined number of bits of the broadcast packet and performs either a tune-up or a tune-down procedure based on the number of cycles counted in which the sampled battery voltage is not equal to the nominal battery voltage for more than one half of a total number of cycles counted.
Inventor(s):	Jani; Nilay (San Jose, CA), Webb; Douglas (Los Altos, CA), Withrington; Jonathan (San Francisco, CA), Berkman; Jeffrey (Saratoga, CA), Li; Haifeng (Sunnyvale, CA)
Assignee:	Proteus Digital Health, Inc. (Redwood City, CA)
Application Number:	14/435,240
Patent Claim Types: see list of patent claims	Use; Device;

Drugs Protected by US Patent 9,268,909

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Otsuka	ABILIFY MYCITE KIT	aripiprazole	TABLET;ORAL	207202-001	Nov 13, 2017		RX	Yes	No			Y			METHOD OF USING A LOGIC CIRCUIT TO STABILIZE BATTERY VOLTAGE SUPPLIED TO A SENSOR EMBEDDED WITH A TABLET AND THAT COMMUNICATES INFORMATION VIA A SIGNAL THROUGH THE BODY OF A PATIENT TO A RECEIVER
Otsuka	ABILIFY MYCITE KIT	aripiprazole	TABLET;ORAL	207202-002	Nov 13, 2017		RX	Yes	Yes			Y			METHOD OF USING A LOGIC CIRCUIT TO STABILIZE BATTERY VOLTAGE SUPPLIED TO A SENSOR EMBEDDED WITH A TABLET AND THAT COMMUNICATES INFORMATION VIA A SIGNAL THROUGH THE BODY OF A PATIENT TO A RECEIVER
Otsuka	ABILIFY MYCITE KIT	aripiprazole	TABLET;ORAL	207202-003	Nov 13, 2017		RX	Yes	No			Y			METHOD OF USING A LOGIC CIRCUIT TO STABILIZE BATTERY VOLTAGE SUPPLIED TO A SENSOR EMBEDDED WITH A TABLET AND THAT COMMUNICATES INFORMATION VIA A SIGNAL THROUGH THE BODY OF A PATIENT TO A RECEIVER
Otsuka	ABILIFY MYCITE KIT	aripiprazole	TABLET;ORAL	207202-004	Nov 13, 2017		RX	Yes	No			Y			METHOD OF USING A LOGIC CIRCUIT TO STABILIZE BATTERY VOLTAGE SUPPLIED TO A SENSOR EMBEDDED WITH A TABLET AND THAT COMMUNICATES INFORMATION VIA A SIGNAL THROUGH THE BODY OF A PATIENT TO A RECEIVER
Otsuka	ABILIFY MYCITE KIT	aripiprazole	TABLET;ORAL	207202-005	Nov 13, 2017		RX	Yes	No			Y			METHOD OF USING A LOGIC CIRCUIT TO STABILIZE BATTERY VOLTAGE SUPPLIED TO A SENSOR EMBEDDED WITH A TABLET AND THAT COMMUNICATES INFORMATION VIA A SIGNAL THROUGH THE BODY OF A PATIENT TO A RECEIVER

Foreign Priority and PCT Information for Patent: 9,268,909

PCT Information
PCT Filed	October 15, 2013	PCT Application Number:	PCT/US2013/065041
PCT Publication Date:	April 24, 2014	PCT Publication Number:	WO2014/062674

International Family Members for US Patent 9,268,909

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2013331417
Brazil	112015008434
Canada	2888871
China	104737532
Denmark	2910013